BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22369682)

  • 1. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
    Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study.
    Andriulli A; Loperfido S; Focareta R; Leo P; Fornari F; Garripoli A; Tonti P; Peyre S; Spadaccini A; Marmo R; Merla A; Caroli A; Forte GB; Belmonte A; Aragona G; Imperiali G; Forte F; Monica F; Caruso N; Perri F
    Am J Gastroenterol; 2008 Dec; 103(12):3011-8. PubMed ID: 19086953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
    Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
    N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of PPI after endoscopic hemostasis in patients with bleeding peptic ulcer and role of Helicobacter pylori.
    Gashi Z; Joksimovic N; Dragusha G; Bakalli A
    Med Arch; 2012; 66(4):236-9. PubMed ID: 22919877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
    Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
    Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
    J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors.
    Mehmedović-Redzepović A; Mesihović R; Prnjavorac B; Kulo A; Merlina K
    Med Glas (Zenica); 2011 Feb; 8(1):151-7. PubMed ID: 21263414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heater probe thermocoagulation for high-risk patients who show rebleeding from peptic ulcers.
    Hsieh YH; Lin HJ
    N Z Med J; 2011 Aug; 124(1341):38-44. PubMed ID: 21959634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers.
    Lo CC; Hsu PI; Lo GH; Lin CK; Chan HH; Tsai WL; Chen WC; Wu CJ; Yu HC; Cheng JS; Lai KH
    Gastrointest Endosc; 2006 May; 63(6):767-73. PubMed ID: 16650535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea.
    Choi KD; Kim N; Jang IJ; Park YS; Cho JY; Kim JR; Shin JM; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1617-24. PubMed ID: 19686407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
    Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
    BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers.
    Hung WK; Li VK; Chung CK; Ying MW; Loo CK; Liu CK; Lam BY; Chan MC
    ANZ J Surg; 2007 Aug; 77(8):677-81. PubMed ID: 17635283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.